Literature DB >> 7509750

Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo.

C Szabó1, C C Wu, S S Gross, C Thiemermann, J R Vane.   

Abstract

We investigated the role of interleukin-1 in the induction of a Ca(2+)-independent nitric oxide (NO) synthase by bacterial endotoxin in vivo. In anaesthetized rats, pretreatment with interleukin-1 receptor antagonist (interleukin-1ra; 16 mg kg-1 i.v., followed by an infusion of 2.4 mg kg-1 h-1) ameliorated the delayed hypotension and tachycardia in response to endotoxin (2 mg kg-1 i.v.). Endotoxaemia for 3 h induced a Ca(2+)-independent NO synthase activity in the lung and reduced the contractions to noradrenaline in the thoracic aorta ex vivo. Treatment with interleukin-1ra attenuated both the induction of NO synthase in the lung (by 46 +/- 5%) and the endotoxin-induced hyporeactivity to noradrenaline in the aorta. Thus, endogenous interleukin-1 contributes to the induction of NO synthase in response to endotoxin in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7509750     DOI: 10.1016/0014-2999(93)90634-t

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli.

Authors:  L Molina; S Studenberg; G Wolberg; W Kazmierski; J Wilson; A Tadepalli; A C Chang; S Kosanke; L Hinshaw
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Co-induction of nitric oxide and tetrahydrobiopterin synthesis in the myocardium in vivo.

Authors:  Y Hattori; S Hattori; S Motohashi; K Kasai; S I Shimoda; N Nakanishi
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

4.  Blockade of nuclear factor-kappaB activation prevents hypodynamic shock and gastric hypoperfusion induced by endotoxin in anesthetized dogs.

Authors:  Chieko Mitaka; Yukio Hirata; Yutaka Narumi; Kuninori Yokoyama; Koshi Makita; Koichi Katsuyama; Takasuke Imai
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

5.  Protective effect of gastrin-releasing peptide receptor antagonist in carrageenan-induced pleural inflammation in rats.

Authors:  Fabricia Petronilho; Bruna de Souza; Francieli Vuolo; César A F Benetton; Emilio L Streck; Rafael Roesler; Gilberto Schwartsmann; Felipe Dal-Pizzol
Journal:  Inflamm Res       Date:  2010-04-03       Impact factor: 4.575

6.  Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.

Authors:  D Hasdai; M Scheinowitz; E Leibovitz; S Sclarovsky; M Eldar; V Barak
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

7.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.

Authors:  S J De Kimpe; M Kengatharan; C Thiemermann; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats.

Authors:  S J De Kimpe; M L Hunter; C E Bryant; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

9.  Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.

Authors:  C C Wu; S J Chen; C Szabó; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  B1 bradykinin receptors and sensory neurones.

Authors:  C L Davis; S Naeem; S B Phagoo; E A Campbell; L Urban; G M Burgess
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.